Skip to main content
logo
Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
2.955
-0.105 (-3.43%)
Jun 8, 2026, 3:43 PM EDT - Market open

Prime Medicine Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
3.184.632.98---
Revenue Growth (YoY)
32.86%55.28%----
Gross Profit
3.184.632.98---
Selling, General & Admin
56.4752.3550.1643.3929.8213.92
Research & Development
154.18160.64155.29147.9186.7370.55
Other Operating Expenses
---13.5--
Total Operating Expenses
210.65212.98205.45204.79116.5484.47
Operating Income
-206.61-208.35-202.47-204.79-116.54-84.47
Interest Income
6.596.637.038.49--
Other Non-Operating Income (Expense)
1.650.58-0.44-2.11-6.23-81.38
Total Non-Operating Income (Expense)
8.247.216.596.38-6.23-81.38
Pretax Income
-52.59-201.14-195.88-198.41-122.77-165.85
Provision for Income Taxes
---0.280.95-0.49
Net Income
-52.59-201.14-195.88-198.69-123.72-165.37
Net Income Attributable to Preferred Dividends
----20.1918.75
Net Income to Common
-198.37-201.14-195.88-198.13-142.01-184.12
Shares Outstanding (Basic)
161149119913413
Shares Outstanding (Diluted)
161149119913413
Shares Change (YoY)
28.62%25.43%30.37%168.41%161.23%391.47%
EPS (Basic)
-1.25-1.35-1.65-2.18-4.19-14.19
EPS (Diluted)
-1.25-1.35-1.65-2.18-4.19-14.19
Free Cash Flow
-158.74-167.1-130.16-174.14-147.92-38.23
Free Cash Flow Per Share
-0.99-1.12-1.10-1.91-4.36-2.95
Gross Margin
100.00%100.00%100.00%---
Operating Margin
-6501.32%-4498.06%-6787.36%---
Profit Margin
-1654.85%-4342.44%-6566.61%---
FCF Margin
-4994.97%-3607.41%-4363.36%---
EBITDA
-199.14-201.03-196.34-200.14-114.32-83.91
EBITDA Margin
-6266.05%-4340.00%-6581.93%---
EBIT
-206.61-208.35-202.47-204.79-116.54-84.47
EBIT Margin
-6501.32%-4498.06%-6787.36%---
Effective Tax Rate
-0.00%0.00%-0.14%-0.77%0.29%
SEC Filings: 10-K · 10-Q